Magnetic Resonance Imaging News and Research

RSS

Magnetic resonance imaging (MRI) is an imaging technique which physicians use for the diagnosis and treatment of medical conditions.

Study finds breast MRI equipment in U.S. meets ACRIN and EUSOBI standards

An overwhelming majority of Breast Cancer Surveillance Consortium (BCSC) facilities performing breast magnetic resonance imaging (MRI) in the U.S. are up-to-par with American College of Radiology Imaging Network (ACRIN) and European Society of Breast Imaging (EUSOBI) technical standards and requirements, according to a study in the November issue of the Journal of the American College of Radiology.

1 Nov 2010

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

The Methodist Hospital Research Institute® (TMHRI) today opened a 12-story, 440,000 square foot research facility dedicated solely to research and equipped with the world's most advanced technology to help research scientists, physicians and engineers cure diseases that afflict today's patients.

28 Oct 2010

NSF awards Rutgers $1.82M grant to acquire Siemens Trio 3T MRI scanner

The last couple decades have seen a virtual renaissance of neuroscience discovery, largely aided by the advanced technology of functional magnetic resonance imaging (fMRI).

28 Oct 2010

More effective therapeutic exercises underutilized in treatment of chronic neck pain

Duke University and University of North Carolina (UNC) researchers report in the November issue of Arthritis Care & Research that narcotics and diagnostic testing are overused in treating chronic neck pain. Their findings indicate clinicians may overlook more effective treatments for neck pain, such as therapeutic exercise. According to reviews cited in the study, evidence to support the effectiveness of therapeutic exercise in treating chronic neck pain is good, yet only 53% of subjects were prescribed such exercise.

28 Oct 2010

Rush University awards $25 million contract to Siemens

Rush University Medical Center in Chicago, one of the top academic medical centers in the United States, has awarded a five-year, $25 million contract for medical equipment and health IT consulting services to Siemens Medical Solutions USA, Inc. With the addition of Siemens medical imaging equipment and software, Rush will become one of a select group of medical centers in the country incorporating the concept of an interventional platform within its facility.

From Siemens Healthineers 27 Oct 2010

Study finds anti-obesity drug reduces brain’s response to appetizing foods

Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.

27 Oct 2010

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.

26 Oct 2010

Colour of light influences the way brain processes emotional stimuli

Researchers at the Cyclotron Research Centre (University of Liege), Geneva Center for Neuroscience and Swiss Center for Affective Sciences (University of Geneva), and Surrey Sleep Research Centre (University of Surrey) investigated the immediate effect of light, and of its color composition, on emotion brain processing using functional magnetic resonance imaging. The results of their study show that the colour of light influences the way the brain processes emotional stimuli.

26 Oct 2010

Marathon running without proper training can damage the heart

Is running a marathon good for you or can it damage the heart?

25 Oct 2010

NCRR awards 450 Recovery Act instrumentation grants to NIH-funded scientists

Leading-edge, shared technologies are an important component of advancing research to improve health. Specialized instruments such as high-powered electron microscopes, high-resolution mass spectrometers and supercomputers that rapidly process vast amounts of data can enable breakthrough discoveries in preventions, treatments and cures for diseases.

22 Oct 2010

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.

22 Oct 2010

New findings shed light on how brain wires itself during first few years of life

A new paper from MIT neuroscientists, in collaboration with Alvaro Pascual-Leone at Beth Israel Deaconess Medical Center, offers evidence that it is easier to rewire the brain early in life. The researchers found that a small part of the brain's visual cortex that processes motion became reorganized only in the brains of subjects who had been born blind, not those who became blind later in life.

22 Oct 2010

Motherhood may cause brain to grow

Motherhood may actually cause the brain to grow, not turn it into mush, as some have claimed. Exploratory research published by the American Psychological Association found that the brains of new mothers bulked up in areas linked to motivation and behavior, and that mothers who gushed the most about their babies showed the greatest growth in key parts of the mid-brain.

21 Oct 2010

Mothers who gush about babies grow bigger brains

21 Oct 2010

Researchers identify common link among malignant tumor types in all grades of cancer

Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ultimately provide a new diagnostic or therapeutic target to detect cancer early or stop tumor growth.

21 Oct 2010

A universal cancer treatment for a universal cancer marker

A latest study shows that a hormone receptor normally confined to the reproductive organs is found in malignant tumors in many parts of the body. Researchers from the Mt. Sinai School of Medicine in New York City explained that this may mean a new target for the early diagnosis and treatment of cancer. The study was published in the latest issue of The New England Journal of Medicine.

20 Oct 2010

Study reveals sex hormones can influence structure and function of heart's right ventricle

In the largest human study to date on the topic, researchers have uncovered evidence of the possible influence of human sex hormones on the structure and function of the right ventricle (RV) of the heart.

20 Oct 2010

Study shows impaired insulin sensitivity may serve as mediator between obesity and cognitive decline

Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.

20 Oct 2010

Genentech and Biogen Idec announce positive results from ocrelizumab phase II RRMS study

Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.

15 Oct 2010

Sanofi-aventis announces TEMSO phase III study results for relapsing multiple sclerosis

Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).

15 Oct 2010

Magnetic Resonance Imaging News and Research

Further Reading

Study finds breast MRI equipment in U.S. meets ACRIN and EUSOBI standards

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

NSF awards Rutgers $1.82M grant to acquire Siemens Trio 3T MRI scanner

More effective therapeutic exercises underutilized in treatment of chronic neck pain

Rush University awards $25 million contract to Siemens

Study finds anti-obesity drug reduces brain’s response to appetizing foods

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Colour of light influences the way brain processes emotional stimuli

Marathon running without proper training can damage the heart

NCRR awards 450 Recovery Act instrumentation grants to NIH-funded scientists

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

New findings shed light on how brain wires itself during first few years of life

Motherhood may cause brain to grow

Mothers who gush about babies grow bigger brains

Researchers identify common link among malignant tumor types in all grades of cancer

A universal cancer treatment for a universal cancer marker

Study reveals sex hormones can influence structure and function of heart's right ventricle

Study shows impaired insulin sensitivity may serve as mediator between obesity and cognitive decline

Genentech and Biogen Idec announce positive results from ocrelizumab phase II RRMS study

Sanofi-aventis announces TEMSO phase III study results for relapsing multiple sclerosis

Streamlining magnetic bead separation processes through standardization eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News